Codiak BioSciences, Inc. Operating Lease Cost
Codiak BioSciences, Inc. reported Operating Lease Cost of $1.24 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2022-11-03
- Codiak BioSciences, Inc. operating lease, cost for the quarter ending 2022-09-30 was $1.24M, a 2.65% increase year-over-year.
- Codiak BioSciences, Inc. operating lease, cost for the quarter ending 2022-06-30 was $1.24M, a 2.56% increase year-over-year.
- Codiak BioSciences, Inc. operating lease, cost for the quarter ending 2022-03-31 was $1.24M, a 2.56% increase year-over-year.
- Codiak BioSciences, Inc. operating lease, cost for the quarter ending 2021-12-31 was $1.26M, a 3.89% increase year-over-year.
- Codiak BioSciences, Inc. operating lease, cost for fiscal 2021 was $4.88M, a 0.95% increase from fiscal 2020.
- Codiak BioSciences, Inc. operating lease, cost for fiscal 2020 was $4.84M, a 7.00% decline from fiscal 2019.
- Codiak BioSciences, Inc. operating lease, cost for fiscal 2019 was $5.20M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.24M 10-Q · filed 2022-11-03 | $2.48M derived: sum of 2 quarters · filed 2022-11-03 | $3.72M 10-Q · filed 2022-11-03 | $4.98M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $1.24M 10-Q · filed 2022-08-04 | $2.48M 10-Q · filed 2022-08-04 | $3.74M derived: sum of 3 quarters · filed 2022-08-04 | $4.94M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $1.24M 10-Q · filed 2022-05-05 | $2.50M derived: sum of 2 quarters · filed 2022-05-05 | $3.70M derived: sum of 3 quarters · filed 2022-11-03 | $4.91M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.46M derived: sum of 2 quarters · filed 2022-11-03 | $3.67M derived: sum of 3 quarters · filed 2022-11-03 | $4.88M 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.21M 10-Q · filed 2022-11-03 | $2.42M derived: sum of 2 quarters · filed 2022-11-03 | $3.63M 10-Q · filed 2022-11-03 | $4.83M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.21M 10-Q · filed 2022-08-04 | $2.42M 10-Q · filed 2022-08-04 | $3.63M derived: sum of 3 quarters · filed 2022-08-04 | $4.83M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $1.21M 10-Q · filed 2022-05-05 | $2.42M derived: sum of 2 quarters · filed 2022-05-05 | $3.62M derived: sum of 3 quarters · filed 2022-05-05 | $4.83M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.42M derived: sum of 2 quarters · filed 2022-03-10 | $3.62M derived: sum of 3 quarters · filed 2022-03-10 | $4.84M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.21M 10-Q · filed 2021-11-04 | $2.42M derived: sum of 2 quarters · filed 2021-11-04 | $3.63M 10-Q · filed 2021-11-04 | $5.13M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $1.21M 10-Q · filed 2021-08-05 | $2.42M 10-Q · filed 2021-08-05 | $3.92M derived: sum of 3 quarters · filed 2021-08-05 | $5.62M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.21M 10-Q · filed 2021-05-06 | $2.71M derived: sum of 2 quarters · filed 2021-05-06 | $4.41M derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $3.20M derived: sum of 2 quarters · filed 2021-03-17 | $5.20M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $1.70M 10-Q · filed 2020-11-19 | $3.70M 10-Q · filed 2020-11-19 |